Grant: Doctoral Research Award: Canada Graduate Scholarships
University of Toronto
$105,000.00
Modelling Chr13q Deletion in Human Hematopoietic Stem Cells and its Role in Clonal Hematopoiesis and the Pre-Leukemic State
FY 2022-23
Summary
Supervisor: Dr. John E. Dick; Institution: University of Toronto.
Every day, 18 Canadians are diagnosed with leukemia and 10 die from this devastating blood cancer. Although leukemia usually happens when a normal blood-producing stem cell accumulates changes in their DNA that occur over decades, leukemia patients only seek medical attention when they experience symptoms and life-threatening complications. Thus, there is great need for earlier detection and intervention. Recently, we identified pre-leukemic blood-producing stem cells up to a decade before a patient's diagnosis, setting the stage for a new approach to predict leukemic risk in asymptomatic individuals. However, there are no available treatments to stop leukemia progression in high-risk individuals despite the breakthrough in early detection. To address this gap, I will create a humanized pre-leukemia model by generating changes specific to the pre-leukemic state in healthy human blood-producing stem cells using gene editing technology, and placing them into immune-compromised mice to observe its effects in cell maintenance and blood cell production. A distinct bias in the types and numbers of cells produced will reveal potential clinical diagnostic indicators of pre-leukemia. I will also apply state-of-the-art single-cell sequencing technology and computational methods to identify unique networks that govern the pre-leukemic state in these stem cells. Future studies can therapeutically exploit these networks by targeting candidates that specifically govern the pre-leukemic blood-producing stem cells, while leaving the normal blood-producing stem cells unharmed. Overall, the results from this study will uncover the nature of pre-leukemic blood-producing stem cells and illustrate a trajectory for pre-leukemia development. My findings offer a new strategy for bringing early intervention approaches into the healthcare system for leukemia prevention.
Department
Program
Doctoral Research Award: Canada Graduate Scholarships
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
475724
Name
Wong Gordon
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Cancer Research
Theme2
Biomedical
Prcname2
Doctoral Research Awards - A
Projecttitle
Modelling Chr13q Deletion in Human Hematopoietic Stem Cells and its Role in Clonal Hematopoiesis and the Pre-Leukemic State
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$105,000
Cihrequipment2
$0
Programname2
Doctoral Research Award: Canada Graduate Scholarships
Keyworddelim
Age-Related Clonal Hematopoiesis; Crispr-Cas9 Genomic Engineering; Pre-Leukemic Stem Cell; Single-Cell In Vitro Differentiation Assay; Single-Cell Multi-Ome Assay (Atac+Rna-Seq); Xenotransplantation
Abstract
Supervisor: Dr. John E. Dick; Institution: University of Toronto.
Every day, 18 Canadians are diagnosed with leukemia and 10 die from this devastating blood cancer. Although leukemia usually happens when a normal blood-producing stem cell accumulates changes in their DNA that occur over decades, leukemia patients only seek medical attention when they experience symptoms and life-threatening complications. Thus, there is great need for earlier detection and intervention. Recently, we identified pre-leukemic blood-producing stem cells up to a decade before a patient's diagnosis, setting the stage for a new approach to predict leukemic risk in asymptomatic individuals. However, there are no available treatments to stop leukemia progression in high-risk individuals despite the breakthrough in early detection. To address this gap, I will create a humanized pre-leukemia model by generating changes specific to the pre-leukemic state in healthy human blood-producing stem cells using gene editing technology, and placing them into immune-compromised mice to observe its effects in cell maintenance and blood cell production. A distinct bias in the types and numbers of cells produced will reveal potential clinical diagnostic indicators of pre-leukemia. I will also apply state-of-the-art single-cell sequencing technology and computational methods to identify unique networks that govern the pre-leukemic state in these stem cells. Future studies can therapeutically exploit these networks by targeting candidates that specifically govern the pre-leukemic blood-producing stem cells, while leaving the normal blood-producing stem cells unharmed. Overall, the results from this study will uncover the nature of pre-leukemic blood-producing stem cells and illustrate a trajectory for pre-leukemia development. My findings offer a new strategy for bringing early intervention approaches into the healthcare system for leukemia prevention.
Competitiondate
202211
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Wong, Gordon
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $105,000~ $0~